Back to Search
MARC COHEN, MD
MD
Cardiovascular Disease Physician
NPI: 1376510578IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
25MA07509200(NJ)
Interventional Cardiology Physician
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
25MA07509200(NJ)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
25MA07509200(NJ)
CMS Specialties
PrimaryINTERVENTIONAL CARDIOLOGY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1977
Research & Publications (20)
Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.
PMID 19181649·Mayo Clin Proc·2009
6-review
Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
PMID 19472347·Catheter Cardiovasc Interv·2009
6-review
Re-evaluating risk factors for periprocedural complications during percutaneous coronary intervention in patients with unstable angina/non-ST-elevation myocardial infarction: who may benefit from more intensive antiplatelet therapy?
PMID 19077819·Curr Opin Cardiol·2009
6-review
Cardiorespiratory measures before and after feeding challenge in term infants are related to birth weight.
PMID 19397552·Acta Paediatr·2009
8-other
The use of adjunctive anticoagulants in patients with acute coronary syndrome transitioning to percutaneous coronary intervention.
PMID 18926355·Am J Emerg Med·2008
6-review
Bleeding after antithrombotic therapy in patients with acute ischemic heart disease: is it the drugs or how we use them?
PMID 18080799·J Thromb Thrombolysis·2008
8-other
High-risk acute coronary syndrome patients with non-ST-elevation myocardial infarction: definition and treatment.
PMID 18592363·Cardiovasc Drugs Ther·2008
6-review
Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm.
PMID 18373600·J Cardiovasc Electrophysiol·2008
6-review
Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial.
PMID 17502577·Circulation·2007
3-trial
Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
PMID 18180524·J Invasive Cardiol·2007
6-review
The challenge of ST-segment elevation myocardial infarction.
PMID 17941831·Int J Clin Pract·2007
6-review
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
PMID 17010793·J Am Coll Cardiol·2006
4-observational
At six months, enoxaparin is more effective than tinzaparin for people with non ST-segment elevation acute coronary syndromes.
PMID 16530671·Evid Based Cardiovasc Med·2006
8-other
The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction.
PMID 16082602·J Thromb Thrombolysis·2005
3-trial
Low-molecular-weight heparin in patients with acute ST-segment elevation myocardial infarction.
PMID 15860994·Am Heart Hosp J·2005
6-review
Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes.
PMID 15811213·Curr Med Res Opin·2005
6-review
The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction.
PMID 14724872·Am J Emerg Med·2004
6-review
Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial.
PMID 14605015·Circulation·2003
3-trial
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial.
PMID 14563573·J Am Coll Cardiol·2003
3-trial
The role of low-molecular-weight heparin in the management of acute coronary syndromes.
PMID 12644342·J Am Coll Cardiol·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 LYONS AVE
NEWARK, NJ 07112 - Phone
- (973) 926-7852
Quick Facts
- NPI
- 1376510578
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile